chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnant patient received the first dose; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the first dose) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Sep-2020 and the estimated date of delivery was 12-Jun-2021. On 01-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the first dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 01-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Oct-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No treatment information provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: some arm soreness; swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle; swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle; swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (some arm soreness), PERIPHERAL SWELLING (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle), VACCINATION SITE ERYTHEMA (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle) and VACCINATION SITE PRURITUS (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE for Blood pressure, ATORVASTATIN for Cholesterol, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle), VACCINATION SITE ERYTHEMA (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle) and VACCINATION SITE PRURITUS (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle). On an unknown date, the patient experienced PAIN IN EXTREMITY (some arm soreness). On 02-Feb-2021, PERIPHERAL SWELLING (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle), VACCINATION SITE ERYTHEMA (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle) and VACCINATION SITE PRURITUS (swollen arm, with some redness and a really bad itchiness, so much it woke them up in the middle) had resolved. At the time of the report, PAIN IN EXTREMITY (some arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications Atorvastatin, Amlodipine, Multivitamins Treatment details were not provided.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site pruritus
Clinical narrative: Bright red spot at the injection site; Itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Bright red spot at the injection site) and VACCINATION SITE PRURITUS (Itching) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) mRNA-1273. On 24-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Bright red spot at the injection site) and VACCINATION SITE PRURITUS (Itching). At the time of the report, INJECTION SITE ERYTHEMA (Bright red spot at the injection site) and VACCINATION SITE PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Sluggishness
Clinical narrative: Arm sore to the touch; Felt sluggish; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN IN EXTREMITY (Arm sore to the touch) and SLUGGISHNESS (Felt sluggish) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included CARVEDILOL, TAMSULOSIN, LISINOPRIL and APIXABAN (ELIQUIS) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm sore to the touch) and SLUGGISHNESS (Felt sluggish). At the time of the report, PAIN IN EXTREMITY (Arm sore to the touch) and SLUGGISHNESS (Felt sluggish) outcome was unknown.            No treatment information were reported   This case was linked to MOD-2021-029940, MOD-2021-030271, MOD-2021-030014 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Heart rate increased, Nausea, Swelling face
Clinical narrative: feeling flushed in my face; my face got puffy; I was nauseated for 2 days; I had extreme fatigue; racing heartbeat; This spontaneous case was reported by a health care professional and describes the occurrence of FLUSHING (feeling flushed in my face), SWELLING FACE (my face got puffy), NAUSEA (I was nauseated for 2 days), FATIGUE (I had extreme fatigue) and HEART RATE INCREASED (racing heartbeat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FLUSHING (feeling flushed in my face), SWELLING FACE (my face got puffy), NAUSEA (I was nauseated for 2 days), FATIGUE (I had extreme fatigue) and HEART RATE INCREASED (racing heartbeat). At the time of the report, FLUSHING (feeling flushed in my face), SWELLING FACE (my face got puffy), NAUSEA (I was nauseated for 2 days), FATIGUE (I had extreme fatigue) and HEART RATE INCREASED (racing heartbeat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 38-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 01-May-2020 and the estimated date of delivery was 05-Feb-2021. On 28-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  forty-first week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.      Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Updated Reporter information and vaccine dosage information
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dermatitis allergic, Injection site erythema, Injection site pruritus, Rash macular
Clinical narrative: Skin allergies but a little more intensive; Injection site itchiness; Injection site Redness; Blotchiness; Skin allergies but a little more intensive; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Blotchiness), DERMATITIS ALLERGIC (Skin allergies but a little more intensive), CONDITION AGGRAVATED (Skin allergies but a little more intensive), INJECTION SITE PRURITUS (Injection site itchiness) and INJECTION SITE ERYTHEMA (Injection site Redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. G07M2CA) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced RASH MACULAR (Blotchiness), DERMATITIS ALLERGIC (Skin allergies but a little more intensive), INJECTION SITE PRURITUS (Injection site itchiness) and INJECTION SITE ERYTHEMA (Injection site Redness). On an unknown date, the patient experienced CONDITION AGGRAVATED (Skin allergies but a little more intensive). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Blotchiness), DERMATITIS ALLERGIC (Skin allergies but a little more intensive), INJECTION SITE PRURITUS (Injection site itchiness) and INJECTION SITE ERYTHEMA (Injection site Redness) had resolved and CONDITION AGGRAVATED (Skin allergies but a little more intensive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Additional event added, skin allergies but a little more intensive.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Dizziness) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 11-Feb-2021, DIZZINESS (Dizziness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Patient noticed a red spot on injection site(left arm), 3X3 inches big,; injection site itchy; injection site warm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Patient noticed a red spot on injection site(left arm), 3X3 inches big,), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE WARMTH (injection site warm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included VITAMINS;AMINO ACIDS for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Patient noticed a red spot on injection site(left arm), 3X3 inches big,), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE WARMTH (injection site warm). At the time of the report, INJECTION SITE ERYTHEMA (Patient noticed a red spot on injection site(left arm), 3X3 inches big,), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE WARMTH (injection site warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: Feeling like she has flu; Slight fever; A spontaneous report was received from a consumer concerning herself of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and had a feeling like she had flu / influenza like illness and a slight fever / pyrexia.  The patient's medical history was not provided. Concomitant product use was not provided.  On 27 Feb 2021, approximately three days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) via unknown route for prophylaxis of COVID-19 infection.   On 01 Mar 2021, the patient had a feeling like she had flu with a slight fever of 101 and the day before i.e. on 28 Feb 2021 she had a fever of 101.5.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events had a feeling like she has flu with a slight fever was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diplopia, Dry mouth, Headache, Injection site pruritus
Clinical narrative: Hot at injection site; Double Vision; Itching at injection site; Headache; Very dry mouth, not a drop of spit; Chills; Soar arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soar arm), INJECTION SITE WARMTH (Hot at injection site), DRY MOUTH (Very dry mouth, not a drop of spit), DIPLOPIA (Double Vision) and HEADACHE (Headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soar arm) and CHILLS (Chills). On 26-Feb-2021, the patient experienced DRY MOUTH (Very dry mouth, not a drop of spit) and HEADACHE (Headache). On 28-Feb-2021, the patient experienced INJECTION SITE WARMTH (Hot at injection site), DIPLOPIA (Double Vision) and INJECTION SITE PRURITUS (Itching at injection site). On 26-Feb-2021, DRY MOUTH (Very dry mouth, not a drop of spit) and CHILLS (Chills) had resolved. On 28-Feb-2021, DIPLOPIA (Double Vision) had resolved. On 01-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, PAIN IN EXTREMITY (Soar arm), INJECTION SITE WARMTH (Hot at injection site) and INJECTION SITE PRURITUS (Itching at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported  Treatment information was not provided   Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain in extremity
Clinical narrative: Hot at injection site; Double Vision; Itching at injection site; Headache; Very dry mouth, not a drop of spit; Chills; Soar arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soar arm), INJECTION SITE WARMTH (Hot at injection site), DRY MOUTH (Very dry mouth, not a drop of spit), DIPLOPIA (Double Vision) and HEADACHE (Headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soar arm) and CHILLS (Chills). On 26-Feb-2021, the patient experienced DRY MOUTH (Very dry mouth, not a drop of spit) and HEADACHE (Headache). On 28-Feb-2021, the patient experienced INJECTION SITE WARMTH (Hot at injection site), DIPLOPIA (Double Vision) and INJECTION SITE PRURITUS (Itching at injection site). On 26-Feb-2021, DRY MOUTH (Very dry mouth, not a drop of spit) and CHILLS (Chills) had resolved. On 28-Feb-2021, DIPLOPIA (Double Vision) had resolved. On 01-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, PAIN IN EXTREMITY (Soar arm), INJECTION SITE WARMTH (Hot at injection site) and INJECTION SITE PRURITUS (Itching at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported  Treatment information was not provided   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, Vertigo
Clinical narrative: Nausea,; Diziness; Vertigo; Fatigue; chills; This spontaneous case was reported by a physician and describes the occurrence of NAUSEA (Nausea,), DIZZINESS (Diziness), VERTIGO (Vertigo), FATIGUE (Fatigue) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 27-Feb-2021, the patient experienced FATIGUE (Fatigue) and CHILLS (chills). On 28-Feb-2021, the patient experienced NAUSEA (Nausea,), DIZZINESS (Diziness) and VERTIGO (Vertigo). On 27-Feb-2021, FATIGUE (Fatigue) and CHILLS (chills) had resolved. On 28-Feb-2021, NAUSEA (Nausea,), DIZZINESS (Diziness) and VERTIGO (Vertigo) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Lab data: Blood pressure 160/78 (normal) and Heart rate 52  Concomitant product: Medicine for cholesterol  Treatment product was not consumed   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Facial and widespread numbness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Facial and widespread numbness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced HYPOAESTHESIA (Facial and widespread numbness). At the time of the report, HYPOAESTHESIA (Facial and widespread numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: left arm is sore from the site of injection to the wrist; feels tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm is sore from the site of injection to the wrist) and FATIGUE (feels tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (left arm is sore from the site of injection to the wrist) and FATIGUE (feels tired). At the time of the report, PAIN IN EXTREMITY (left arm is sore from the site of injection to the wrist) and FATIGUE (feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash spreading on the arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash spreading on the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced RASH (Rash spreading on the arm). At the time of the report, RASH (Rash spreading on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Ear discomfort, Rash macular
Clinical narrative: red blotches all over his hand; hot ears; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (red blotches all over his hand) and EAR DISCOMFORT (hot ears) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 28-Feb-2021, the patient experienced RASH MACULAR (red blotches all over his hand) and EAR DISCOMFORT (hot ears). At the time of the report, RASH MACULAR (red blotches all over his hand) and EAR DISCOMFORT (hot ears) outcome was unknown.            Concomitant product use was not reported  Treatment information was not provided   Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Vaccination site pain
Clinical narrative: Big rash at the injection site; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Big rash at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 17-Feb-2021, the patient experienced INJECTION SITE RASH (Big rash at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Big rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Antibiotics
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred, Visual field defect
Clinical narrative: Little blind spot on the right eye for about 15 minutes; Sort of waviness blind spot; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL FIELD DEFECT (Little blind spot on the right eye for about 15 minutes) and VISION BLURRED (Sort of waviness blind spot) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VISUAL FIELD DEFECT (Little blind spot on the right eye for about 15 minutes) and VISION BLURRED (Sort of waviness blind spot). On 15-Feb-2021, VISUAL FIELD DEFECT (Little blind spot on the right eye for about 15 minutes) and VISION BLURRED (Sort of waviness blind spot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.        No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: numbness in the lower lip; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (numbness in the lower lip) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced HYPOAESTHESIA ORAL (numbness in the lower lip). At the time of the report, HYPOAESTHESIA ORAL (numbness in the lower lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Eczema. Concomitant products included DUPILUMAB (DUPIXENT) for Eczema.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 15-Jan-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided    It was reported that after reaction of shingles patient had gone to the urgent care on 15-JAN-2021 and patient was not able to remember the medication prescribed for shingles. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Patient details updated, reporter details updated, concomitant drug detail updated, medical history detail updated, first dose and second dose details updated
Sex: F
Vaccine: COVID19
Symptoms: Chills, Temperature intolerance, Tremor
Clinical narrative: Extreme cold and freezing; Shaking; had chills to where she felt she was having a seizure; This spontaneous case was reported by a consumer and describes the occurrence of TEMPERATURE INTOLERANCE (Extreme cold and freezing), TREMOR (Shaking) and CHILLS (had chills to where she felt she was having a seizure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Colonoscopy. Concomitant products included HYDROCHLOROTHIAZIDE, THYROID (ARMOUR THYROID), ZINC, VITAMIN C [ASCORBIC ACID], UBIDECARENONE (COQ 10), FISH OIL, MONASCUS PURPUREUS (RED YEAST RICE) and FUROSEMIDE (LASIX [FUROSEMIDE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced CHILLS (had chills to where she felt she was having a seizure). On an unknown date, the patient experienced TEMPERATURE INTOLERANCE (Extreme cold and freezing) and TREMOR (Shaking). At the time of the report, TEMPERATURE INTOLERANCE (Extreme cold and freezing), TREMOR (Shaking) and CHILLS (had chills to where she felt she was having a seizure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included colon prep medications, No Treatment information provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Increase in fatigue; Muscles in the neck; Headache; Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Muscles in the neck), PAIN IN EXTREMITY (Soreness in the arm) and FATIGUE (Increase in fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced HEADACHE (Headache), MYALGIA (Muscles in the neck) and PAIN IN EXTREMITY (Soreness in the arm). On 22-Feb-2021, the patient experienced FATIGUE (Increase in fatigue). On 08-Feb-2021, HEADACHE (Headache), MYALGIA (Muscles in the neck) and PAIN IN EXTREMITY (Soreness in the arm) had resolved. At the time of the report, FATIGUE (Increase in fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided          No Concomitant medications were provided No Treatment information provided
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Glucose tolerance test, Ultrasound foetal, Ultrasound scan vagina
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J202A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Depression since 2015. Concomitant products included CETIRIZINE HYDROCHLORIDE (CETRIZINE) from 28-Apr-2021 to an unknown date for Allergy, ESCITALOPRAM for Depression, PARACETAMOL (TYLENOL) for Pain, FOLIC ACID and MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] for Prenatal care.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 18-Aug-2020 and the estimated date of delivery was 29-Jun-2021. On 29-Dec-2020, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Nov-2020, Ultrasound scan vagina: normal (normal) Viable intrauterine pregnancy. normal first trimester. On 03-Feb-2021, Ultrasound foetal: normal (normal) consists of 19 weeks baby, normal anatomy, posterior  placenta. On 30-Mar-2021, Glucose tolerance test: normal normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: added  ethnicity concomitant medications, events ,medical history and  lab details  No treatment related information has been reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Pain
Clinical narrative: FATIGUE; PAIN AT INJECTION SITE; Ache; HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache), HEADACHE (HEADACHE), FATIGUE (FATIGUE) and INJECTION SITE PAIN (PAIN AT INJECTION SITE) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (Ache), HEADACHE (HEADACHE) and INJECTION SITE PAIN (PAIN AT INJECTION SITE). On 13-Feb-2021, the patient experienced FATIGUE (FATIGUE). On 12-Feb-2021, PAIN (Ache) and HEADACHE (HEADACHE) had resolved. On 13-Feb-2021, FATIGUE (FATIGUE) and INJECTION SITE PAIN (PAIN AT INJECTION SITE) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes Tylenol.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site rash, Rash, Tenderness
Clinical narrative: Large fist size circle, maybe the size of an orange; developed a rash / large fist size circle, maybe the size of an orange; Sore again / Quite tender; Tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tender arm), INJECTION SITE PAIN (Sore again / Quite tender), INJECTION SITE RASH (developed a rash / large fist size circle, maybe the size of an orange) and RASH (Large fist size circle, maybe the size of an orange) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced TENDERNESS (Tender arm). On 15-Feb-2021, the patient experienced INJECTION SITE PAIN (Sore again / Quite tender). On 16-Feb-2021, the patient experienced INJECTION SITE RASH (developed a rash / large fist size circle, maybe the size of an orange). On 17-Feb-2021, the patient experienced RASH (Large fist size circle, maybe the size of an orange). On 10-Feb-2021, TENDERNESS (Tender arm) had resolved. At the time of the report, INJECTION SITE PAIN (Sore again / Quite tender), INJECTION SITE RASH (developed a rash / large fist size circle, maybe the size of an orange) and RASH (Large fist size circle, maybe the size of an orange) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Vaccination site pain
Clinical narrative: severe Body Jerk; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSKINESIA (severe Body Jerk) and VACCINATION SITE PAIN (Sore Arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DYSKINESIA (severe Body Jerk) and VACCINATION SITE PAIN (Sore Arm). At the time of the report, DYSKINESIA (severe Body Jerk) and VACCINATION SITE PAIN (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Myalgia, Pain in extremity, Pregnancy test
Clinical narrative: sore arm; muscle ache; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle ache) in a 29-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013821A and 042L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension in January 2017, GERD in 2005, Sleep apnea in August 2019, Anxiety in October 2010 and Pregnancy (spontanous  misscarriage) in May 2017. Concurrent medical conditions included Shellfish allergy (shell fish, Peptose). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), VITAMIN C [ASCORBIC ACID], VITAMIN B NOS and ZINC for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 17-May-2021. On 24-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle ache). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 24-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Sep-2021, Pregnancy test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided Patient estimated conception is on 29-08-2020.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Swelling face, Throat tightness
Clinical narrative: Throat felt constricted; A little dizziness; Weakness in his body; Had swelling of face; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Throat felt constricted), DIZZINESS (A little dizziness), ASTHENIA (Weakness in his body) and SWELLING FACE (Had swelling of face) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROAT TIGHTNESS (Throat felt constricted), DIZZINESS (A little dizziness), ASTHENIA (Weakness in his body) and SWELLING FACE (Had swelling of face). At the time of the report, THROAT TIGHTNESS (Throat felt constricted), DIZZINESS (A little dizziness), ASTHENIA (Weakness in his body) and SWELLING FACE (Had swelling of face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported.  Treatment information was not provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Maternal exposure during pregnancy, Ultrasound testes
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 28-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1-2 glasses wine). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 16-Jul-2020 and the estimated date of delivery was 22-Apr-2021. On 26-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 26-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: normal (normal) normal. On an unknown date, Ultrasound testes: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's estimated date of conception was 01-AUG-20201 and tested positive for pregnancy test on 08-AUG-2020.  Patient did not have any complications or acute illness at the time of report.  Patient's ultrasound testing and glucose testing was normal.  There was no treatment medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Updated pregnancy information, lab data
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Flushing, Myalgia, Pyrexia
Clinical narrative: felt tired, exhaustion; sore at the injection site; cheeks flushed; Had body aches; fever since the 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (cheeks flushed), FATIGUE (felt tired, exhaustion), MYALGIA (Had body aches), PYREXIA (fever since the 2nd shot) and VACCINATION SITE PAIN (sore at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rotator cuff tear. Concomitant products included PARACETAMOL (TYLENOL) for Fever and Rotator cuff tear, NAPROXEN SODIUM (ALEVE) for Rotator cuff tear and Fever.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FLUSHING (cheeks flushed), MYALGIA (Had body aches) and PYREXIA (fever since the 2nd shot). On 27-Feb-2021, the patient experienced FATIGUE (felt tired, exhaustion) and VACCINATION SITE PAIN (sore at the injection site). At the time of the report, FLUSHING (cheeks flushed), FATIGUE (felt tired, exhaustion), MYALGIA (Had body aches), PYREXIA (fever since the 2nd shot) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 100f (High) Her fever was running around 100F, 101F, or 99.9F..
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: felt tired, exhaustion; sore at the injection site; cheeks flushed; Had body aches; fever since the 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (cheeks flushed), FATIGUE (felt tired, exhaustion), MYALGIA (Had body aches), PYREXIA (fever since the 2nd shot) and VACCINATION SITE PAIN (sore at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rotator cuff tear. Concomitant products included PARACETAMOL (TYLENOL) for Fever and Rotator cuff tear, NAPROXEN SODIUM (ALEVE) for Rotator cuff tear and Fever.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FLUSHING (cheeks flushed), MYALGIA (Had body aches) and PYREXIA (fever since the 2nd shot). On 27-Feb-2021, the patient experienced FATIGUE (felt tired, exhaustion) and VACCINATION SITE PAIN (sore at the injection site). At the time of the report, FLUSHING (cheeks flushed), FATIGUE (felt tired, exhaustion), MYALGIA (Had body aches), PYREXIA (fever since the 2nd shot) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 100f (High) Her fever was running around 100F, 101F, or 99.9F..